» Articles » PMID: 19147679

Association of NAD(P)H Oxidase with Glucose-induced Insulin Secretion by Pancreatic Beta-cells

Overview
Journal Endocrinology
Specialty Endocrinology
Date 2009 Jan 17
PMID 19147679
Citations 55
Authors
Affiliations
Soon will be listed here.
Abstract

We previously described the presence of nicotinamide adenine dinucleotide phosphate reduced form [NAD(P)H]oxidase components in pancreatic beta-cells and its activation by glucose, palmitic acid, and proinflammatory cytokines. In the present study, the importance of the NAD(P)H oxidase complex for pancreatic beta-cell function was examined. Rat pancreatic islets were incubated in the presence of glucose plus diphenyleneiodonium, a NAD(P)H oxidase inhibitor, for 1 h or with the antisense oligonucleotide for p47(PHOX) during 24 h. Reactive oxygen species (ROS) production was determined by a fluorescence assay using 2,7-dichlorodihydrofluorescein diacetate. Insulin secretion, intracellular calcium responses, [U-(14)C]glucose oxidation, and expression of glucose transporter-2, glucokinase and insulin genes were examined. Antisense oligonucleotide reduced p47(PHOX) expression [an important NAD(P)H oxidase cytosolic subunit] and similarly to diphenyleneiodonium also blunted the enzyme activity as indicated by reduction of ROS production. Suppression of NAD(P)H oxidase activity had an inhibitory effect on intracellular calcium responses to glucose and glucose-stimulated insulin secretion by isolated islets. NAD(P)H oxidase inhibition also reduced glucose oxidation and gene expression of glucose transporter-2 and glucokinase. These findings indicate that NAD(P)H oxidase activation plays an important role for ROS production by pancreatic beta-cells during glucose-stimulated insulin secretion. The importance of this enzyme complex for the beta-cell metabolism and the machinery involved in insulin secretion were also shown.

Citing Articles

NADPH oxidase 5 is a novel susceptibility gene for type 2 diabetes mellitus.

Azarova I, Klyosova E, Azarova V, Polonikov A Arch Endocrinol Metab. 2024; 68:e230527.

PMID: 39529984 PMC: 11554360. DOI: 10.20945/2359-4292-2023-0527.


Redox Status as a Key Driver of Healthy Pancreatic Beta-Cells.

Holendova B, Benakova S, Krivonoskova M, Plecita-Hlavata L Physiol Res. 2024; 73(S1):S139-S152.

PMID: 38647167 PMC: 11412338. DOI: 10.33549/physiolres.935259.


NADPH Dynamics: Linking Insulin Resistance and β-Cells Ferroptosis in Diabetes Mellitus.

Moon D Int J Mol Sci. 2024; 25(1).

PMID: 38203517 PMC: 10779351. DOI: 10.3390/ijms25010342.


Novel regulatory roles of small G protein GDP dissociation stimulator (smgGDS) in insulin secretion from pancreatic β-cells.

Gleason N, Williams C, Kowluru A Mol Cell Endocrinol. 2023; 580():112104.

PMID: 38013223 PMC: 10842139. DOI: 10.1016/j.mce.2023.112104.


Redox Balance in Type 2 Diabetes: Therapeutic Potential and the Challenge of Antioxidant-Based Therapy.

Argaev-Frenkel L, Rosenzweig T Antioxidants (Basel). 2023; 12(5).

PMID: 37237860 PMC: 10215840. DOI: 10.3390/antiox12050994.